Despite the advent of the genomic era, the perceived benefits of close
collaboration between clinicians and scientists are not always realized and the
gap between bench and bedside remains. Closer collaboration should expedite
advances in treating disease. This text, with a foreword by Fritz H Schroder, is
designed to enhance the relationship between the two communities. It contains
data from a multinational authorship, the 40 chapters being written by experts
with widely differing training and expectations. Their aim is to facilitate both
understanding and in-depth knowledge of their subject. By bridging the gap
between clinicians and scientists, the hope is to enhance translational research
in their common goal of improving the diagnosis and treatment of prostate
cancer, the single most important cancer affecting men.